BIOQUEST CORP. Spending and interest coverage
- R&D / revenue · 12 months: Value (m); Formula and calculation Research and development expense / revenue. Period ending 2022-07-31..
- Stock-based compensation / revenue · 12 months: Value (m); Formula and calculation Share-based compensation / revenue. Period ending 2022-07-31..
- Interest coverage · 12 months: Value (m); Formula and calculation Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified..
Spending and interest coverage
Overview →Financial period ending 2022-07-31; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| R&D / revenue · 12 months | (m) | Research and development expense / revenue. Period ending 2022-07-31. Calculation unavailable: missing inputs remain (m). |
| Stock-based compensation / revenue · 12 months | (m) | Share-based compensation / revenue. Period ending 2022-07-31. Calculation unavailable: missing inputs remain (m). |
| Interest coverage · 12 months | (m) | Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Research and development spending | (m) | |
| Revenue | (m) | |
| Stock-based compensation | (m) | Share-based Payment Arrangement, Noncash Expense |
| Operating income | -403.44K USD | Operating Income (Loss) |
| Interest expense · reported / estimated | (m) | Interest Expense · Estimated expense assumptions |
Latest interest expense basis: (m). Estimated values carry *; expand each history row’s basis for its dated balances and rate assumptions.
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Research and development spending (USD) | Revenue (USD) | Stock-based compensation (USD) | Operating income (USD) | Interest expense · reported / estimated (USD) | R&D / revenue | SBC / revenue | Interest coverage | Interest expense basis |
|---|---|---|---|---|---|---|---|---|---|
| 2022-07-31 | (m) | (m) | (m) | $-403.44K | (m) | (m) | (m) | (m) | (m) |
| 2022-04-30 | (m) | (m) | $206.70K | $-817.92K | (m) | (m) | (m) | (m) | (m) |
| 2022-01-31 | (m) | (m) | (m) | (m) | $81.39K | (m) | (m) | (m) | Reported |
| 2021-10-31 | (m) | (m) | (m) | (m) | $94.18K | (m) | (m) | (m) | Reported |
| 2021-07-31 | (m) | (m) | (m) | $-2.34M | $82.29K | (m) | (m) | -28.47× | Reported |
| 2021-04-30 | (m) | (m) | (m) | (m) | $37.64K | (m) | (m) | (m) | Reported |
| 2021-01-31 | (m) | (m) | $152.50K | $-1.65M | $19.42K | (m) | (m) | -84.91× | Reported |
| 2020-10-31 | (m) | (m) | (m) | $-1.28M | (m) | (m) | (m) | (m) | (m) |
| 2020-07-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-04-30 | (m) | (m) | $117.27K | $-356.55K | $2.48K | (m) | (m) | -144.06× | Reported |
| 2020-01-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2019-10-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2015-01-31 | (m) | $30.98K | (m) | $-3.05M | (m) | (m) | (m) | (m) | (m) |
| 2014-10-31 | (m) | $29.82K | (m) | $-2.15M | (m) | (m) | (m) | (m) | (m) |
| 2014-04-30 | (m) | $0.00 | (m) | $-123.71K | (m) | (m) | (m) | (m) | (m) |
| 2014-01-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2013-10-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2013-07-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2013-04-30 | (m) | $0.00 | (m) | $-8.28K | (m) | (m) | (m) | (m) | (m) |
| 2013-01-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2012-10-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2012-07-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.